Yu Li
- SEC CIK
- 0001777275
No open-market purchases or sales filed in the past year.
Current role at each company
- IMDX Insight Molecular Diagnostics Inc.VP Cntrllr/Prncpl Acctng Offcras of May 19, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Yu Li as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2022 (view filing) | May 18 | 1 day | Yu LiVP Cntrllr/Prncpl Acctng Offcr | SSaleCommon Stock, no par value | −8.13K | $1.14 | −$9.27K | −32.5%16.9K after |